Бульдозер Б12        Погрузчик В140        Автогрейдер ДЗ-98В
Новости | Иносми | Культура | Рынки | Челябинск | Hi-tech | Здоровье | Спорт


02.10.2025 3:51
Pfizer Drug Price Cuts Yield Three-Year Trump Tariff Respite, Lilly Deal Could Be Next Pfizer secured a reprieve from President Donald Trump’s long-threatened tariffs on the pharmaceutical industry by agreeing to slash some of its drug prices by up to 85% and selling directly to the American public, a move other major drugmakers are expected to follow. In exchange, the company gained a three-year grace period from widely anticipated pharmaceutical tariffs. It’s the latest example of the transactional nature of winning tariff exemptions from Trump, who has unilaterally wielded trade policy to exert power over multiple industries. Similar deals could be forthcoming. Eli Lilly said it’s in active discussions with the administration to further expand patient access, as the announcement underscores the urgency of making medicines more affordable. Bloomberg News Health Reporter Damian Garde and Kalderos CEO Angie Franks join Bloomberg Businessweek Daily to discuss. They speak with Carol Massar and Tim Stenovec. (Source: Bloomberg)

02.10.2025 3:36
Shutdown May Dull OBBB Benefits: Wharton Budget Chief Kent Smetters, faculty director of the University of Pennsylvania’s Wharton Budget Lab, says a prolonged government shutdown could disrupt public services and weigh on GDP. He speaks with Romaine Bostick and Katie Greifeld on “The Close.” (Source: Bloomberg)


Страницы:  1  2  3  4  5  6  7  8  9  10  11  12   ... 1526  1527  1528  1529  1530  1531  1532  1533  1534  1535  1536  1537  1538  1539  1540  1541  1542  1543  1544  1545  1546  1547  1548  1549  1550  1551  1552  1553  1554  1555  1556  1557  1558  1559